+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Tuberculosis Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Radiographic Method, Diagnostic Laboratory Methods, Nucleic Acid Testing, Phage Assay), By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 110 Pages
  • September 2023
  • Region: Global
  • Grand View Research
  • ID: 5893234
The global tuberculosis diagnostics market size is expected to reach USD 3.34 billion by 2030, registering a CAGR of 5.2% from 2023 to 2030. Advent of advanced diagnostic methods such as Interferon-gamma Release Assay (IGRA), serological methods, and nucleic acid testing have resulted in the high usage rate of diagnostics. Moreover, Point of Care (POC) technologies such as antigen assays are also promoting the diagnosis rate of TB.

These advanced methods including POC diagnostics are affordable, accurate, simple, and yield quick results. Furthermore, the rising burden of TB is the primary factor responsible for the lucrative market growth. As per the World Health Organization, the global estimates of patients afflicted with TB were around 9.6 million in 2014. This high prevalence rate has led the government, healthcare organizations, research institutes, and market players to initiate endeavors directed toward containing the incidence of this infectious disease.

The increasing screening rate in the high burden regions, affordability of diagnostics, advanced methodologies, faster clinical decisions, and reduction in mortality rate are the focal areas of development. Improved preventive and curative diagnosis rates are the end results of these initiatives. This has led to a subsequent upsurge in the demand for diagnostic tests and the TB diagnostics market.

Tuberculosis Diagnostics Market Report Highlights

  • Based on tests type, the tuberculosis diagnostics market is segmented into radiographic methods, diagnostic laboratory methods, nucleic acid testing, phage assay, detection of latent infection, cytokine detection assay, and detection of drug resistance.
  • Diagnostic laboratory tests dominated the test type segment with 38.0% market share in 2015 as they are cost efficient and easy-to-perform. Diagnostic laboratory tests include smear microscopy and culture-based tests. The high burden regions rely on these methodologies due to their financial and technical incapability to incorporate advanced technologies thus contributing to the growth of the diagnostic laboratory tests segment.
  • However, compromised accuracy and the longer processing time are the limiting factor for the diagnostics. Hence, healthcare agencies are striving to implement advanced techniques in the developing regions.
  • As a result, nucleic acid tests segment and the latent infection detection segment, which includes skin tests and IGRA, are likely to exhibit a profitable growth rate. These methods overcome the aforementioned limitations thus improving affordability, processing time and accuracy of the diagnostic method.
  • Drug resistance in tuberculosis is one of the primary concerns for healthcare professionals as improper treatment due to wrong drug regimen and incorrect dosage forms lead to the development of drug resistance in TB patients undergoing treatment. Hence, the drug resistance detection segment is also anticipated to witness lucrative growth.
  • Asia Pacific owing to its huge population base and high burden of TB dominated the global TB diagnostics market in 2015. As per the WHO, countries such as India, China, Afghanistan, and Indonesia are priority regions for control of this communicable disease.
  • The players in the TB testing market include Thermo Fisher Scientific, Inc., Hologic Corporation, Abbott Laboratories, Alere, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche AG, bioMérieux SA, Sanofi, Cepheid, Hain Lifescience GmbH, and QIAGEN.
  • New product launches, collaboration, mergers & acquisitions, and regional expansion are the key strategic initiatives undertaken by these industry players
  • For instance, in July 2016, bioMérieux launched a novel CE marked database and reagents kit VITEK MS for the identification of TB. This new product launch is anticipated to help the company increase its market share.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Test Type
1.1.2. End-use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Test type outlook
2.2.2. End-use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Tuberculosis Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Tuberculosis Diagnostics Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Tuberculosis Diagnostics: Test Type Estimates & Trend Analysis
4.1. Tuberculosis Diagnostics Market: Key Takeaways
4.2. Tuberculosis Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Radiographic Method
4.3.1. Radiographic method market estimates and forecasts, 2018 to 2030, (USD Million)
4.4. Diagnostic Laboratory Methods
4.4.1. Diagnostic laboratory methods market estimates and forecasts, 2018 to 2030, (USD Million)
4.5. Nucleic Acid Testing
4.5.1. Nucleic acid testing market estimates and forecasts, 2018 to 2030, (USD Million)
4.6. Phage Assay
4.6.1. Phage assay market estimates and forecasts, 2018 to 2030, (USD Million)
4.7. Detection of Latent Infection (Skin Test & IGRA)
4.7.1. Detection of latent infection market estimates and forecasts, 2018 to 2030, (USD Million)
4.8. Cytokine Detection Assay
4.8.1. Cytokine detection assay market estimates and forecasts, 2018 to 2030, (USD Million)
4.9. Detection of Drug Resistance (DST)
4.9.1. Detection of drug resistance (DST) market estimates and forecasts, 2018 to 2030, (USD Million)
4.10. Other Methods
4.10.1. Other methods market estimates and forecasts, 2018 to 2030, (USD Million)
Chapter 5. Tuberculosis Diagnostics: End-use Estimates & Trend Analysis
5.1. Tuberculosis Diagnostics Market: Key Takeaways
5.2. Tuberculosis Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Diagnostic Laboratories
5.3.1. Diagnostic laboratories market estimates and forecasts, 2018 to 2030, (USD Million)
5.4. Hospitals & Clinics
5.4.1. Hospitals & clinics market estimates and forecasts, 2018 to 2030, (USD Million)
5.5. Others
5.5.1. Others market estimates and forecasts, 2018 to 2030, (USD Million)
Chapter 6. Tuberculosis Diagnostics Market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Tuberculosis Diagnostics Market by Region: Key Takeaways
6.3. North America
6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.2. U.S.
6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.3. Canada
6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.2. Germany
6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.3. France
6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.4. Italy
6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.5. Spain
6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.6. Sweden
6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.7. Norway
6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.8. Denmark
6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.2. China
6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.3. India
6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.4. Australia
6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.5. Thailand
6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.6. South Korea
6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6.2. Mexico
6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6.3. Argentina
6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7. MEA
6.7.1. Saudi Arabia
6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.2. South Africa
6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.3. UAE
6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.4. Kuwait
6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Market Participant Categorization
7.2.1. Abbott Laboratories
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Becton, Dickinson and Company
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. F. Hoffmann-La Roche AG
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Thermo Fisher Scientific Inc.
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. BioMérieux SA
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Hain Lifescience GmbH
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. QIAGEN GmbH
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Cepheid
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Hologic, Inc.
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. BD
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 North America tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 3 North America tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 4 North America tuberculosis diagnostics market, by region, 2018 - 2030 (USD Million)
Table 5 U.S. tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 6 U.S. tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 7 Canada tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 8 Canada tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 9 Europe tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 10 Europe tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 11 Europe tuberculosis diagnostics market, by region, 2018 - 2030 (USD Million)
Table 12 Germany tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 13 Germany tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 14 UK tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 15 UK tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 16 France tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 17 France tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 18 Italy tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 19 Italy tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 20 Spain tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 21 Spain tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 22 Sweden tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 23 Sweden tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 24 Norway tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 25 Norway tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 26 Denmark tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 27 Denmark tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 28 Asia Pacific tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 29 Asia Pacific tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 30 Asia Pacific tuberculosis diagnostics market, by region, 2018 - 2030 (USD Million)
Table 31 China tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 32 China tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 33 Japan tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 34 Japan tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 35 India tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 36 India tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 37 Australia tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 38 Australia tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 39 Thailand tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 40 Thailand tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 41 South Korea tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 42 South Korea tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 43 Latin America tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 44 Latin America tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 45 Latin America tuberculosis diagnostics market, by region, 2018 - 2030 (USD Million)
Table 46 Brazil tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 47 Brazil tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 48 Mexico tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 49 Mexico tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 50 Argentina tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 51 Argentina tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 52 Middle East and Africa tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 53 Middle East and Africa tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 54 Middle East and Africa tuberculosis diagnostics market, by region, 2018 - 2030 (USD Million)
Table 55 South Africa tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 56 South Africa tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 59 UAE tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 60 UAE tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 61 Kuwait tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 62 Kuwait tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Tuberculosis diagnostics: Market outlook
Fig. 9 Tuberculosis diagnostics: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Tuberculosis diagnostics market driver impact
Fig. 15 Tuberculosis diagnostics market restraint impact
Fig. 16 Tuberculosis diagnostics market strategic initiatives analysis
Fig. 17 Tuberculosis diagnostics market: Test type movement analysis
Fig. 18 Tuberculosis diagnostics market: Test type outlook and key takeaways
Fig. 19 Radiographic method market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Diagnostic laboratory methods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Nucleic acid testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Phage assay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Detection of latent infection (skin test & IGRA) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Cytokine detection assay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Detection of drug resistance (DST) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Other methods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Tuberculosis diagnostics market: End-use movement analysis
Fig. 28 Tuberculosis diagnostics market: End-use outlook and key takeaways
Fig. 29 Diagnostic laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Hospitals & clinics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Global tuberculosis diagnostics market: Regional movement analysis
Fig. 33 Global tuberculosis diagnostics market: Regional outlook and key takeaways
Fig. 34 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Companies Mentioned

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche AG
  • Thermo Fisher Scientific Inc.
  • BioMérieux SA
  • Hain Lifescience GmbH
  • QIAGEN GmbH
  • Cepheid
  • Hologic, Inc.
  • BD

Methodology

Loading
LOADING...

Table Information